Qube Research & Technologies (QRT)’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
Qube Research & Technologies (QRT)'s ATRC Position: Q3 2026 in Review
Qube Research & Technologies (QRT) sold out of AtriCure (ATRC) in Q3 2026, closing a stake of 560,824 shares — an estimated $15.7M sold.
Qube Research & Technologies (QRT) first reported a position in ATRC in Q2 2020 and held it in 15 quarters. The position peaked at $15.7M in Q2 2026. 286 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.
- Qube Research & Technologies (QRT) reported no remaining AtriCure position as of Q3 2026 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 560,824 AtriCure shares in Q3 2026, an estimated $15.7M.
- Qube Research & Technologies (QRT) first reported a position in AtriCure in Q2 2020 and held it in 15 quarters.
- Qube Research & Technologies (QRT)'s AtriCure position peaked at $15.7M in Q2 2026.
- 286 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.